FULGENT GENETICS, INC. Amortization of Intangible Assets
FULGENT GENETICS, INC. (FLGT) reported Amortization of Intangible Assets of $2.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-07-30
- FULGENT GENETICS, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $2.60M, a 30.80% increase year-over-year.
- FULGENT GENETICS, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $2.03M, a 2.06% increase year-over-year.
- FULGENT GENETICS, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $2.03M, a 1.71% increase year-over-year.
- FULGENT GENETICS, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $2.02M, a 1.61% increase year-over-year.
- FULGENT GENETICS, INC. amortization of intangible assets for fiscal 2025 was $8.03M, a 0.83% increase from fiscal 2024.
- FULGENT GENETICS, INC. amortization of intangible assets for fiscal 2024 was $7.96M, a 1.53% increase from fiscal 2023.
- FULGENT GENETICS, INC. amortization of intangible assets for fiscal 2023 was $7.84M, a 20.75% increase from fiscal 2022.
- FULGENT GENETICS, INC. amortization of intangible assets for fiscal 2022 was $6.50M, a 280.39% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.60M 10-Q · filed 2026-07-30 | $4.63M 10-Q · filed 2026-07-30 | $6.66M derived: sum of 3 quarters · filed 2026-07-30 | $8.69M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $2.03M 10-Q · filed 2026-05-01 | $4.06M derived: sum of 2 quarters · filed 2026-05-01 | $6.08M derived: sum of 3 quarters · filed 2026-05-01 | $8.07M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.05M derived: sum of 2 quarters · filed 2026-02-27 | $6.04M derived: sum of 3 quarters · filed 2026-07-30 | $8.03M 10-K · filed 2026-02-27 |
| 2025-09-30 | $2.02M 10-Q · filed 2025-11-07 | $4.01M derived: sum of 2 quarters · filed 2026-07-30 | $6.00M 10-Q · filed 2025-11-07 | $8.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $1.99M 10-Q · filed 2026-07-30 | $3.98M 10-Q · filed 2026-07-30 | $5.97M derived: sum of 3 quarters · filed 2026-07-30 | $7.96M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $1.99M 10-Q · filed 2026-05-01 | $3.98M derived: sum of 2 quarters · filed 2026-05-01 | $5.97M derived: sum of 3 quarters · filed 2026-05-01 | $7.96M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.98M derived: sum of 2 quarters · filed 2026-02-27 | $5.97M derived: sum of 3 quarters · filed 2026-02-27 | $7.96M 10-K · filed 2026-02-27 |
| 2024-09-30 | $1.99M 10-Q · filed 2025-11-07 | $3.98M derived: sum of 2 quarters · filed 2025-11-07 | $5.97M 10-Q · filed 2025-11-07 | $7.93M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $1.99M 10-Q · filed 2025-08-01 | $3.98M 10-Q · filed 2025-08-01 | $5.94M derived: sum of 3 quarters · filed 2026-02-27 | $7.89M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $1.99M 10-Q · filed 2025-05-02 | $3.95M derived: sum of 2 quarters · filed 2026-02-27 | $5.91M derived: sum of 3 quarters · filed 2026-02-27 | $7.87M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.92M derived: sum of 2 quarters · filed 2026-02-27 | $5.88M derived: sum of 3 quarters · filed 2026-02-27 | $7.84M 10-K · filed 2026-02-27 |
| 2023-09-30 | $1.96M 10-Q · filed 2024-11-08 | $3.92M derived: sum of 2 quarters · filed 2024-11-08 | $5.89M 10-Q · filed 2024-11-08 | $7.90M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $1.96M 10-Q · filed 2024-08-02 | $3.93M 10-Q · filed 2024-08-02 | $5.94M derived: sum of 3 quarters · filed 2024-08-02 | $7.95M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $1.97M 10-Q · filed 2024-05-03 | $3.98M derived: sum of 2 quarters · filed 2024-05-03 | $5.98M derived: sum of 3 quarters · filed 2024-05-03 | $7.56M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $2.01M 10-K · filed 2023-02-28 | $4.02M derived: sum of 2 quarters · filed 2023-11-03 | $5.59M derived: sum of 3 quarters · filed 2023-11-03 | $6.50M 10-K · filed 2025-02-28 |
| 2022-09-30 | $2.01M 10-Q · filed 2023-11-03 | $3.58M derived: sum of 2 quarters · filed 2023-11-03 | $4.49M 10-Q · filed 2023-11-03 | $5.40M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $1.57M 10-Q · filed 2023-08-04 | $2.48M 10-Q · filed 2023-08-04 | $3.39M derived: sum of 3 quarters · filed 2023-08-04 | $4.19M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $906.00K 10-Q · filed 2023-05-05 | $1.82M derived: sum of 2 quarters · filed 2023-05-05 | $2.61M derived: sum of 3 quarters · filed 2023-05-05 | |
| 2021-12-31 | $911.00K 10-K · filed 2023-02-28 | $1.71M derived: sum of 2 quarters · filed 2023-02-28 | $1.71M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $797.00K 10-K · filed 2023-02-28 | $797.00K 10-Q · filed 2022-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |